Delshadi Mohammad, Arjmand Hasan, Imannezhad Shima, Mostafavi Maryam, Mohammadi Yasaman, Naeim Mahdi
Department of Research, Psychology and Counseling Organization, Tehran, Iran.
Department of Nursing, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Ann Med Surg (Lond). 2024 Jun 10;86(8):4521-4526. doi: 10.1097/MS9.0000000000002254. eCollection 2024 Aug.
Group cognitive-behavioral therapy has demonstrated its effectiveness in treating various psychological disorders. Nevertheless, there is insufficient evidence supporting its application in enhancing both the quality of life and depression among Parkinson's patients. Consequently, this study was undertaken to examine the efficacy of group cognitive-behavioral therapy in ameliorating depression symptoms and enhancing the quality of life in individuals afflicted with Parkinson's disease.
A randomized clinical trial with pre-test and post-test measurements, including a control group, was conducted. The sample consisted of individuals referred to Roozbeh Hospital in Tehran with Parkinson's disease in 2023. Ninety participants were selected using convenience sampling and randomly assigned to either an experimental or a control group, with 45 participants in each. The experimental group received a three-month cognitive-behavioral therapy intervention consisting of 12 sessions of 90 min. Pre-test and post-test measures included the Beck Depression Questionnaire and the World Health Organization Quality of Life Questionnaire. Data analysis was performed using multivariate analysis of covariance (MANCOVA) in SPSS-25.
The results revealed a significant difference between the experimental and control groups in terms of depression and quality of life. The cognitive-behavioral therapy intervention significantly reduced depression and significantly improved the quality of life in individuals with Parkinson's disease (≤0.01).
Group cognitive-behavioral therapy can be an effective approach for reducing depression and improving the quality of life in individuals with Parkinson's disease. Therefore, therapists and healthcare providers can utilize cognitive-behavioral therapy to enhance the well-being of individuals with Parkinson's disease.
团体认知行为疗法已证明其在治疗各种心理障碍方面的有效性。然而,缺乏证据支持其在提高帕金森病患者生活质量和缓解抑郁方面的应用。因此,本研究旨在探讨团体认知行为疗法对改善帕金森病患者抑郁症状和提高生活质量的疗效。
进行了一项包括对照组的前后测随机临床试验。样本包括2023年转诊至德黑兰鲁兹贝赫医院的帕金森病患者。采用便利抽样法选取90名参与者,并随机分为实验组和对照组,每组45人。实验组接受为期三个月的认知行为疗法干预,共12节,每节90分钟。前后测指标包括贝克抑郁问卷和世界卫生组织生活质量问卷。使用SPSS-25中的多变量协方差分析(MANCOVA)进行数据分析。
结果显示,实验组和对照组在抑郁和生活质量方面存在显著差异。认知行为疗法干预显著降低了帕金森病患者的抑郁程度,并显著提高了他们的生活质量(P≤0.01)。
团体认知行为疗法可以成为减轻帕金森病患者抑郁和提高其生活质量的有效方法。因此,治疗师和医疗服务提供者可以利用认知行为疗法来提高帕金森病患者的幸福感。